The Patent Finder
AU

Aarhus Universitet

First filing 2003
OverviewNotableFeesChangesFamiliesPatent listSources & methods

31 patents currently held

10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Aug 2027. from the record

Of the 10 now held by other companies, 2 name Qiagen GmbH as their current owner, and 8 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Aug 2027
Next term end
26
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Nov 19 to 23, 2026 · next Nov 19
  • 2 fees due Dec 6 to 25, 2026 · next Dec 6
  • 1 fee due Feb 20, 2027
    The maintenance fee for Method for Determining Clinically Relevant Hypoxia in Cancer (US 10,385,399) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

What they patent

The 5 largest of its 26 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 8,003,002P-Type Thermoelectric Materials, a Process for Their Manufacture and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 8,911,937Method for detecting methylation status by using methylation-independent primers
In force
 · High confidence
In forceHigh confidence
US 9,036,878Method for Delineation of Tissue Lesions
In force
 · High confidence
In forceHigh confidence
US 10,792,000System for Assessing Tissue Substance Extraction
In force
 · High confidence
In forceHigh confidence
US 10,385,399Method for Determining Clinically Relevant Hypoxia in Cancer
In force
 · High confidence
In forceHigh confidence
US 9,540,633High Expression Cereal Phytase Gene
In force
 · High confidence
In forceHigh confidence
US 9,872,871Compositions for Use in Restoring Muscle Glycogen and/or Muscle Mass
In force
 · High confidence
In forceHigh confidence
US 10,328,048Cafestol for Treating Diabetes
In force
 · High confidence
In forceHigh confidence
US 10,166,253Positively Charged Co-Polymers for Use as Antimicrobial Agents
In force
 · High confidence
In forceHigh confidence
US 9,922,444Image Processing Apparatus and Method
In force
 · High confidence
In forceHigh confidence
10 of 31 patents shown.
Pro members see all 31.
Pro members: see all 31 patents
Also on record, not counted in the 31: 10 patents in force now held by others · 35 patents ended · 69 applications pending · 114 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited